Kripa Shankar

Dr. Kripa Shankar

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 March 2019 in Endocrinology
Verified
Journal Article
Closed access
PDF file
BMBharath K Mani
Bharath K Mani
KSKripa Shankar
Kripa Shankar
JZJeffrey Zigman
Jeffrey Zigman
Much effort has been directed at studying the orexigenic actions of administered ghrelin and the potential effects of the endogenous ghrelin system on food intake, food reward, body weight, adiposity, and energy expenditure. Although endogenous ghrelin’s actions on some of these processes remain ambiguous, its glucoregulatory actions have emerged as well-recognized features during extreme metabolic conditions. The blood glucose-raising actions of ghrelin are beneficial during starvation-like conditions, defending against life-threatening falls in blood glucose, but are seemingly detrimental in obese states and in certain monogenic forms of diabetes, contributing to hyperglycemia. Also of interest, blood glucose negatively regulates ghrelin secretion. This article reviews the literature suggesting the existence of a blood glucose-ghrelin axis and highlights the factors that mediate the glucoregulatory actions of ghrelin, especially during metabolic extremes such as starvation and diabetes.

1 June 2014 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
SVSalil Varshney
Salil Varshney
KSKripa Shankar
Kripa Shankar
MBMuheeb Beg
Muheeb Beg
VBVishal M. Balaramnavar
Vishal M. Balaramnavar
SMSunil Kumar Mishra
Sunil Kumar Mishra
AGAnil Nilkanth Gaikwad
Anil Nilkanth Gaikwad
We developed a common feature pharmacophore model using known antiadipogenic compounds (CFPMA). We identified rohitukine, a reported chromone anticancer alkaloid as a potential hit through in silico mapping of the in-house natural product library on CFPMA. Studies were designed to assess the antiadipogenic potential of rohitukine. Rohitukine was isolated from Dysoxylum binacteriferum Hook. to ⬧95% purity. As predicted by CFPMA, rohitukine was indeed found to be an antiadipogenic molecule. Rohitukine inhibited lipid accumulation and adipogenic differentiation in a concentration- and exposure-time-dependent manner in 3T3-L1 and C3H10T1/2 cells. Rohitukine downregulated expression of PPARγ, CCAAT/enhancer binding protein α, adipocyte protein 2 (aP2), FAS, and glucose transporter 4. It also suppressed mRNA expression of LPL, sterol-regulatory element binding protein (SREBP) 1c, FAS, and aP2, the downstream targets of PPARγ. Rohitukine arrests cells in S phase during mitotic clonal expansion. Rohitukine was bioavailable, and 25.7% of orally administered compound reached systemic circulation. We evaluated the effect of rohitukine on dyslipidemia induced by high-fat diet in the hamster model. Rohitukine increased hepatic expression of liver X receptor α and decreased expression of SREBP-2 and associated targets. Rohitukine decreased hepatic and gonadal lipid accumulation and ameliorated dyslipidemia significantly. In summary, our strategy to identify a novel antiadipogenic molecule using CFPMA successfully resulted in identification of rohitukine, which confirmed antiadipogenic activity and also exhibited in vivo antidyslipidemic activity.

1 January 2018 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
SRSujith Rajan
Sujith Rajan
SPSurendra Puri
Surendra Puri
DKDurgesh Kumar
Durgesh Kumar
MBMadala Hari Babu
Madala Hari Babu
KSKripa Shankar
Kripa Shankar
AGAnil N. Gaikwad
Anil N. Gaikwad

1 July 2019 in European Journal of Pharmacology
Verified
Journal Article
Closed access
KSKripa Shankar
Kripa Shankar
DKDurgesh Kumar
Durgesh Kumar
SGSanchita Gupta
Sanchita Gupta
SVSalil Varshney
Salil Varshney
SRSujith Rajan
Sujith Rajan
AGAnil Nilkanth Gaikwad
Anil Nilkanth Gaikwad

1 December 2018 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
DKDurgesh Kumar
Durgesh Kumar
KSKripa Shankar
Kripa Shankar
SPSaraswati Patel
Saraswati Patel
AGAbhishek Gupta
Abhishek Gupta
SVSalil Varshney
Salil Varshney
AGAnil N. Gaikwad
Anil N. Gaikwad

1 March 2014 in Phytomedicine
Verified
Journal Article
Closed access
MBMuheeb Beg
Muheeb Beg
PCParul Chauhan
Parul Chauhan
SVSalil Varshney
Salil Varshney
KSKripa Shankar
Kripa Shankar
SRSujith Rajan
Sujith Rajan
AGAnil Nilkanth Gaikwad
Anil Nilkanth Gaikwad